Pancreatic Cancer Research

ResearcherTianjin First Center HospitalNo recent work listed

Chuan Gu

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-4823-5613; OpenAlex author ID A5101766407.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
1
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper

Papers 2

  1. MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39. Last author DOI 10.1155/2017/2381482↗
  2. MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer. Last author DOI 10.1002/iub.1342↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Rende Guo · 2 shared papers, 2015–2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.